Mode
Text Size
Log in / Sign up
Phase 4 Completed N=80 Treatment

Effects of Adrenaline Infiltration on Surgical Field of View in Endoscopic Sinus Surgery

Intraoperative Bleeding
Source: ClinicalTrials.gov NCT05867342 ↗
Enrolled (actual)
80
Serious AEs
0.0%
Results posted
Jul 2023
Primary outcomePrimary: Surgical Field Grading Score — 3.54; 3.23 score on a scale — p=0.77
◆ Published Evidence
Emerging
15citations · ~3 / year
The effect of topical epinephrine 1:1000 with and without infiltration of 1% lidocaine with epinephrine 1:100,000 on endoscopic surgical field visualization: a double-blind randomized controlled study.
International forum of allergy & rhinology · 2020 · High-confidence link

Summary

In endoscopic sinus surgery a clear surgical field of view is a very important aspect for good surgical outcome. This study is to evaluate the preoperative preparation to acquire best surgical field of view by comparing between the use of topical adrenaline and the use of combination of topical adrenaline with infiltration of 1% lidocaine with adrenaline in patients scheduled for endoscopic sinus surgery for rhinosinusitis.

Linked Publications

  • The effect of topical epinephrine 1:1000 with and without infiltration of 1% lidocaine with epinephrine 1:100,000 on endoscopic surgical field visualization: a double-blind randomized controlled study.
    International forum of allergy & rhinology · 2020 · 15 citations · High-confidence link

Outcome Measures

OutcomeResultp-value
PRIMARY
Surgical Field Grading Score
3.54; 3.23 0.77
SECONDARY
Duration of Surgery
72.05; 54.23 0.002 sig
SECONDARY
Number of Extra Pledgets Used
3.25; 2.63 0.126
SECONDARY
Estimated Blood Loss During Surgery
95.25; 91.63
SECONDARY
Postoperative Bloody Discharge Grading Score
2.38; 2.2 0.213
SECONDARY
Number of Days With Postoperative Bloody Nasal Discharge
2.85; 2.73 0.418
SECONDARY
Number of Nostrils With Continuous Fresh Bleeding
7; 5 0.756

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with recurrent acute or chronic rhinosinusitis recalcitrant to medical treatment and scheduled for endoscopic sinus surgery

Exclusion Criteria

  • Patients who have asymetrical disease on the two sides (Lund Mackay score difference more than 2)
  • Patients who have endoscopic sinus surgery for treatment of tumor or disease other than sinusitis
  • Patients with underlying uncontrolled hypertension
  • Patients with bleeding disorder or are unable to discontinue antiplatelet or anticoagulant before the surgery
  • Patients who are allergic to adrenaline or to xylocaine
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05867342) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search